Timeline: The Hypoallergenic Cat

The Hypoallergenic Cat: A Timeline Feb. 4, 2004 The beginnings of the allergy-free cat. Simon Brodie and David Avner agree on a business plan for using RNAi to knock out the gene for the major cat allergen fel d 1. Sept. 24, 2004 Brodie and Avner agree to form a company called Allerca. Oct. 12, 2004 Brodie backs out of his partnership with Avner. Oct. 26, 2004 Brodie incorporates Allerca without Avner. Oct. 28, 200

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The Hypoallergenic Cat: A Timeline
Feb. 4, 2004
The beginnings of the allergy-free cat. Simon Brodie and David Avner agree on a business plan for using RNAi to knock out the gene for the major cat allergen fel d 1.
Sept. 24, 2004
Brodie and Avner agree to form a company called Allerca.
Oct. 12, 2004
Brodie backs out of his partnership with Avner.
Oct. 26, 2004
Brodie incorporates Allerca without Avner.
Oct. 28, 2004
Brodie sends out press releases promising hypoallergenic cats based on RNAi by 2007. "For the first time, people who have been unable to own a cat because of their allergies will be able to have a pet of their own without the associated risks and costs of allergy treatments."
Dec. 14, 2004
Avner sues Brodie for stealing and publicizing his trade secrets, soliciting his customers, and usurping investors, "because it appears, from the public's perspective, that [Allerca has] already 'cornered the market' on this new technology."
Jan. 31, 2005
U.S. District court in Colorado orders an injunction on Allerca "not to reenter the market for genetically engineered allergen-free cats until after 5/31/06."
Jan. 31, 2005
The Scientist publishes "Doubts About Allergy-Free Cats."
Spring 2005
Allerca scientists begin screening cats randomly across the country and in the United Kingdom to try out a fel d 1 genetic test with the intention of developing fel d 1 knockout cats.
Fall 2005
Allerca scientists stumble upon cats with a mutant fel d 1 that renders them hypoallergenic; they determine that the trait is dominant and begin breeding (cat gestation takes 57-69 days; cats reach maturity in 6-10 months).
Spring 2006
Second generation of hypoallergenic cats is born.
May-July 2006
Hired by Allerca, Microbac conducts genetic analysis on samples of hypoallergenic cats and concludes Allerca's cats have mutations not seen in control cats.
May 31, 2006
Injunction is lifted, allowing Allerca to pursue development of allergy-free cats.
June 7, 2006
Allerca announces it has bred hypoallergenic cats and begins accepting deposits.
Sept. 14 2006
In a press release Allerca announces success in independent clinical trials. "This observation exposure shows the Allerca cat has hypoallergenicity."
Fall 2006
Third generation of hypoallergenic cats is born.
Spring 2007
Allerca's scheduled delivery of hypoallergenic cats to customers.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery